hmmm it is OK to assume that I work in Australia post but you did make a valid point that "something they should have thought about long ago".... !
I am not a doctor or science person and certainly don't work for Australia post but is there any other scope of OSL apart from liver they talked in past? As in my opinion they should skip liver all together and try to diversify into something more add on to existing device they got or something completely different.
companies like this https://histosonics.com/ may hold promising hopes, if they succeed but obviously it will be a very long time before something comes out from them... IMO.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $19.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $24.67K | 4.285M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1800000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 16832747 | 23 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |